Definite regression of cutaneous melanoma metastases upon addition of topical contact sensitizer diphencyprone to immune checkpoint inhibitor treatment. Article uri icon

Overview

publication date

  • July 1, 2016

Research

keywords

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • Cyclopropanes
  • Melanoma
  • Skin Neoplasms

Identity

PubMed Central ID

  • PMC4927368

Scopus Document Identifier

  • 84977138630

Digital Object Identifier (DOI)

  • 10.1111/exd.13030

PubMed ID

  • 27061281

Additional Document Info

volume

  • 25

issue

  • 7